Colorectal cancer Dahkki Nicum, S, Midgley, R, Kerr, D

Colorectal cancer. Dahkki Nicum, S, Midgley, R, Kerr, D

Chemotherapy for colorectal cancer. Dahkki Nicum, S, Midgley, R, Kerr, D

Malignant mesothelioma with unexpected contralateral mediastinal shift: a case report Dahkki Myerson James S, Nicum Shibani, Sharma Bhupinder, O'Brien Mary ER

Viečča ollesdeavstta

The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy. Dahkki Grumett, SA, Archer, V, Midgley, R, Mulholland, P, Nicum, S, Blewitt, L, Kerr, D

Randomised phase II trial of olaparib, chemotherapy, or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol Dahkki Mansouri, A, McGregor, N, Dunn, R, Dobbie, S, Holmes, J, Collins, L, Nicum, S

Comparative analysis of conventionally and additively manufactured acetabular shells from a single manufacturer Dahkki Harry Hothi, Johann Henckel, Arya Nicum, Anna Di Laura, Klaus Schlueter-Brust, Alister Hart

Viečča ollesdeavstta

Characterisation of 3D-printed acetabular hip implants Dahkki Arya Nicum, Harry Hothi, Johann Henckel, Anna di Laura, Klaus Schlueter-Brust, Alister Hart

Viečča ollesdeavstta

Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol Dahkki Rachel Dunn, Shibani Nicum, Anita Mansouri, Naomi McGregor, Sam Dobbie, Jane Holmes, Linda Collins

Viečča ollesdeavstta

OCTOVA: A randomised phase II trial of olaparib, chemotherapy, or olaparib and cediranib in patients with BRCA-mutated platinumresistant ovarian cancer Dahkki Nicum, S, Strauss, V, McGregor, N, McNeish, I, Roux, R, Hall, M, Michael, A, Roberts, C

A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol Dahkki Nicum, S, Roberts, C, Boyle, L, Kopijasz, S, Gourley, C, Hall, M, Montes, A, Poole, C, Collins, L, Schuh, A, Dutton, S

Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours Dahkki Roberts, C, Strauss, VY, Kopijasz, S, Gourley, C, Hall, M, Montes, A, Abraham, J, Clamp, A, Kennedy, R, Banerjee, S, Folkes, LK, Stratford, M, Nicum, S

Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors. Dahkki Nicum, S, Brooks, C, Wharton, R, Boyle, L, Kaye, S, Gourley, C, Hall, M, Montes, A, Pearson, SR, Julier, P, Midgley, R, Schuh, A, Dutton, S, Grp, 6

An adaptive study to determine the optimal dose of the tablet formulation of the PARP inhibitor olaparib Dahkki Mateo, J, Moreno, V, Gupta, A, Kaye, S, Dean, E, Middleton, M, Friedlander, M, Gourley, C, Plummer, R, Rustin, G, Sessa, C, Leunen, K, Ledermann, J, Swaisland, H, Fielding, A, Bannister, W, Nicum, S, Molife, L

Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells Dahkki Artibani, M, Masuda, K, Hu, Z, Rauher, PC, Mallett, G, Wietek, N, Morotti, M, Chong, K, KaramiNejadRanjbar, M, Zois, CE, Dhar, S, El-Sahhar, S, Campo, L, Blagden, SP, Damato, S, Pathiraja, PN, Nicum, S, Gleeson, F, Laios, A, Alsaadi, A, Santana Gonzalez, L, Motohara, T, Albukhari, A, Lu, Z, Bast Jr., RC, Harris, AL, Ejsing, CS, Klemm, RW, Yau, C, Sauka-Spengler, T, Ahmed, AA

Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells Dahkki Mara Artibani, Kenta Masuda, Zhiyuan Hu, Pascal C. Rauher, Garry Mallett, Nina Wietek, Matteo Morotti, Kay Chong, Mohammad KaramiNejadRanjbar, Christos E. Zois, Sunanda Dhar, Salma El-Sahhar, Leticia Campo, Sarah P. Blagden, Stephen Damato, Pubudu N. Pathiraja, Shibani Nicum, Fergus Gleeson, Alexandros Laios, Abdulkhaliq Alsaadi, Laura Santana Gonzalez, Takeshi Motohara, Ashwag Albukhari, Zhen Lu, Robert C. Bast Jr., Adrian L. Harris, Christer S. Ejsing, Robin W. Klemm, Christopher Yau, Tatjana Sauka-Spengler, Ahmed Ashour Ahmed

Viečča ollesdeavstta